Targeting split vaccines to the endosome improves vaccination

Current Opinion in Biotechnology

Volumn 15, Issue 6, 2004, Pages 538-542

  Wagner, Hermann ^a   Heit, Antje ^a   Schmitz, Frank ^a   Bauer, Stefan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELLS; IMMUNOGENECITY; MAJOR HISTOCOMPATIBILITY COMPLEX (MHC); VACCINATION;

ANTIGENS; BIOTECHNOLOGY; CELLS; CYTOLOGY; IMMUNOLOGY; PROTEINS;

VACCINES;

IMMUNOLOGICAL ADJUVANT; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGODEOXYNUCLEOTIDE; OVALBUMIN; RECOMBINANT ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA SEQUENCE; DRUG TARGETING; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; HUMAN; IMMUNOGENICITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CROSS-PRIMING; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; VACCINES;

EID: 9244234953     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2004.09.006     Document Type: Review

References (40)

1. R. Rappuoli, H.I. Miller, and S. Falkow Medicine. The intangible value of vaccination Science 297 2002 937 939
2. M.M. Levine, and M.B. Sztein Vaccine development strategies for improving immunization: the role of modern immunology Nat Immunol 5 2004 460 464
3. P. Wong, and E.G. Pamer CD8 T cell responses to infectious pathogens Annu Rev Immunol 21 2003 29 70
4. R.M. Zinkernagel On natural and artificial vaccinations Annu Rev Immunol 21 2003 515 546
5. P. Cresswell, N. Bangia, T. Dick, and G. Diedrich The nature of the MHC class I peptide loading complex Immunol Rev 172 1999 21 28
6. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu Rev Immunol 20 2002 621 667
7. M.J. Bevan Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay J Exp Med 143 1976 1283 1288
8. K.S. Schluns, and L. Lefrancois Cytokine control of memory T-cell development and survival Nat Rev Immunol 3 2003 269 279
9. S.M. Kaech, J.T. Tan, E.J. Wherry, B.T. Konieczny, C.D. Surh, and R. Ahmed Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells Nat Immunol 4 2003 1191 1198
10. L.T. Madakamutil, U. Christen, C.J. Lena, Y. Wang-Zhu, A. Attinger, M. Sundarrajan, W. Ellmeier, M.G. von Herrath, P. Jensen, D.R. Littman, and H. Cheroutre CD8αα-mediated survival and differentiation of CD8 memory T cell precursors Science 304 2004 590 593
11. R.M. Steinman, D. Hawiger, and M.C. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 21 2003 685 711
12. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
13. H. Wagner The immunobiology of the TLR9 subfamily Trends Immunol 25 2004 381 386
14. C.C. Norbury, B.J. Chambers, A.R. Prescott, H.G. Ljunggren, and C. Watts Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells Eur J Immunol 27 1997 280 288
15. D.M. Underhill, and A. Ozinsky Phagocytosis of microbes: complexity in action Annu Rev Immunol 20 2002 825 852
16. E. Gagnon, S. Duclos, C. Rondeau, E. Chevet, P.H. Cameron, O. Steele-Mortimer, J. Paiement, J.J. Bergeron, and M. Desjardins Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages Cell 110 2002 119 131 This manuscript points out that the ER membrane fuses with the cell membrane during biogenetics of phago-endosomes.
17. M. Kovacsovics-Bankowski, K. Clark, B. Benacerraf, and K.L. Rock Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages Proc Natl Acad Sci USA 90 1993 4942 4946
18. M. Rescigno, S. Citterio, C. Thery, M. Rittig, D. Medaglini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castagnoli Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells Proc Natl Acad Sci USA 95 1998 5229 5234
19. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89
20. F. Berard, P. Blanco, J. Davoust, E.M. Neidhart-Berard, M. Nouri-Shirazi, N. Taquet, D. Rimoldi, J.C. Cerottini, J. Banchereau, and A.K. Palucka Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells J Exp Med 192 2000 1535 1544
21. J. Wolfers, A. Lozier, G. Raposo, A. Regnault, C. Thery, C. Masurier, C. Flament, S. Pouzieux, F. Faure, and T. Tursz Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Nat Med 7 2001 297 303
22. A. Regnault, D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, and S. Amigorena Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization J Exp Med 189 1999 371 380
23. P. Machy, K. Serre, and L. Leserman Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells Eur J Immunol 30 2000 848 857
24. •] were the first articles to describe endosomes as organelles with competence for cross-presentation.
25. •].
26. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu Rev Immunol 21 2003 335 376
27. •] define single-stranded RNA motifs as ligand for TLR7 (mouse) and TLR8 (human).
28. •].
29. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
30. S. Bauer, C.J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G.B. Lipford Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proc Natl Acad Sci USA 98 2001 9237 9242
31. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, and C. Galanos Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
32. D.M. Underhill, A. Ozinsky, A.M. Hajjar, A. Stevens, C.B. Wilson, M. Bassetti, and A. Aderem The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens Nature 401 1999 811 815
33. G.B. Lipford, M. Bauer, C. Blank, R. Reiter, H. Wagner, and K. Heeg CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants Eur J Immunol 27 1997 2340 2344
34. H. Wagner Bacterial CpG DNA activates immune cells to signal infectious danger Adv Immunol 73 1999 329 368
35. T. Sparwasser, E.S. Koch, R.M. Vabulas, K. Heeg, G.B. Lipford, J.W. Ellwart, and H. Wagner Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells Eur J Immunol 28 1998 2045 2054
36. H.J. Cho, K. Takabayashi, P.M. Cheng, M.D. Nguyen, M. Corr, S. Tuck, and E. Raz Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism Nat Biotechnol 18 2000 509 514
37. T. Maurer, A. Heit, H. Hochrein, F. Ampenberger, M. O'Keeffe, S. Bauer, G.B. Lipford, R.M. Vabulas, and H. Wagner CpG-DNA aided cross-presentation of soluble antigens by dendritic cells Eur J Immunol 32 2002 2356 2364
38. A. Heit, T. Maurer, H. Hochrein, S. Bauer, K.M. Huster, D.H. Busch, and H. Wagner Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells J Immunol 170 2003 2802 2805 This manuscript describes that TLR9 is not involved in endocytosis of CpG-DNA.
39. P. Ahmad-Nejad, H. Hacker, M. Rutz, S. Bauer, R.M. Vabulas, and H. Wagner Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments Eur J Immunol 32 2002 1958 1968 The first description of endosomally expressed TLR9.
40. E. Latz, A. Schoenemeyer, A. Visintin, K.A. Fitzgerald, B.G. Monks, C.F. Knetter, E. Lien, N.J. Nilsen, T. Espevik, and D.T. Golenbock TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nat Immunol 5 2004 190 198 The first work to establish that TLR9 is expressed at the ER in non-activated DCs.